Establishment of Diagnostic Cutoff Points for Levels of Serum Antibodies to Pertussis Toxin, Filamentous Hemagglutinin, and Fimbriae in Adolescents and Adults in the United States

Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Full description

Saved in:
Bibliographic Details
Published inClinical and Diagnostic Laboratory Immunology Vol. 11; no. 6; pp. 1045 - 1053
Main Authors Baughman, Andrew L, Bisgard, Kristine M, Edwards, Kathryn M, Guris, Dalya, Decker, Michael D, Holland, Kathy, Meade, Bruce D, Lynn, Freyja
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.11.2004
Subjects
Adolescent
Adult
Antibodies, Bacterial - blood
Antigens, Bacterial - immunology
Bordetella pertussis
Child
Enzyme-Linked Immunosorbent Assay - standards
Humans
Immunoglobulin G - blood
Microbial Immunology
Middle Aged
United States
Virulence Factors, Bordetella - immunology
Whooping Cough - blood
Whooping Cough - diagnosis
United States
Online AccessGet full text

Cover

More Information
Summary:Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy CVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 1556-6811 Online ISSN: 1556-679X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to CVI .asm.org, visit: CVI       
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Present address: Clinical Trials Office, Vanderbilt-Ingram Cancer Center, Nashville, Tenn.
Corresponding author. Mailing address: National Immunization Program, Centers for Disease Control and Prevention, 1600 Clifton Rd., N.E., Mailstop E-61, Atlanta, GA 30333. Phone: (404) 639-8198. Fax: (404) 639-2483. E-mail: dbaughman@cdc.gov.
Present address: Scientific & Medical Affairs, Aventis Pasteur, Swiftwater, Pa.
ISSN:1556-6811
1071-412X
1556-679X
1098-6588
DOI:10.1128/CDLI.11.6.1045-1053.2004